GlassScriptPhysician profile
Michael S Leong
NPI 1316073109
$7,344.07
in general payments reported to CMS, 2019-2025
19 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,069 · 2020: $336 · 2021: $482 · 2022: $203 · 2023: $1,545 · 2024: $2,075 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,637 · Travel and Lodging: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,637.32 |
| Travel and Lodging | $616.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $1,003.26 | 2023-2025 | Prospera, Biotronik |
| Abbott Laboratories | $970.62 | 2019-2024 | Eterna, Proclaim |
| Mml US, INC. | $958.24 | 2024 | Reactiv8 |
| Boston Scientific Corporation | $815.37 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Painteq LLC | $793.41 | 2021-2024 | Painteq |
| Bioness INC | $746.93 | 2019 | |
| Vertos Medical, INC. | $675.00 | 2019 | |
| Nevro Corp. | $522.53 | 2019-2023 | Senza |
| Si-Bone, INC. | $212.45 | 2020-2025 | |
| Biogen, INC. | $124.28 | 2022 | |
| Nalu Medical, INC. | $100.21 | 2020 | |
| Saluda Medical Americas, INC. | $86.85 | 2023-2024 | Evoke, Evoke Scs |
| Spr Therapeutics, INC | $80.81 | 2024 | Sprint Pns System |
| Stimwave Technologies Incorporated | $77.16 | 2021-2022 | |
| Vertiflex, INC. | $73.94 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $43.60 | 2021 | |
| Tersera Therapeutics LLC | $39.06 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.35 | 2024 | Exparel |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Leong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.